Ever Source Wealth Advisors, LLC Spring Works Therapeutics, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.65 Billion
- Q4 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 50 shares of SWTX stock, worth $2,360. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50
Previous 26
92.31%
Holding current value
$2,360
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SWTX
# of Institutions
235Shares Held
67.2MCall Options Held
260KPut Options Held
316K-
Vanguard Group Inc Valley Forge, PA7.16MShares$338 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$265 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.46MShares$163 Million5.51% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.27MShares$155 Million0.01% of portfolio
-
State Street Corp Boston, MA3MShares$142 Million0.0% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.95B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...